In this webinar, experts discuss how data and analytics can be applied to improve health program outcomes and how social determinants of health affect risk. It includes a case study on how the application of advanced analytic methods helped to decipher the impact of high-priced specialty drugs on the overall population. The experts also address how artificial intelligence can drive better decision-making, improve population health and cut costs.
Published By: MarkLogic
Published Date: May 07, 2018
Learn how Life Sciences organizations can accelerate Real World Evidence by achieving faster time to insight with a metadata-driven, semantically enriched operational platform.
Real World Evidence (RWE) is today’s big data challenge in Life Sciences. Medical records, registries, consultation reports, insurance claims, pharmacy data, social media, and patient surveys all contain valuable insights that Life Sciences organizations need to ascertain and prove the safety, efficacy, and value of their drugs and medical devices.
Learn how Life Sciences organizations can accelerate RWE with a metadata-driven, semantically enriched operational platform that enables them to:
• Unify, harmonize and ensure governance of information from diverse data sources
• Transform information into evidence that proves product efficacy and safety
• Identify data patterns, connections, and relationships for faster time to insight
The intent of this technical bulletin is to summarize and clarify the respiratory protection guidance from both USP and NIOSH for workers who handle hazardous drugs in the healthcare environment. Download now to learn more.
In the age of evolving shopper expectations and technology advancements, the global retail industry is in the midst of a profound shift in retail operations. To gain a deeper understanding of retailers’ focus, concerns and investment plans, Zebra conducted a global research study across a wide spectrum of retail segments, including: specialty stores, department stores, apparel merchants, supermarkets, electronics, home improvement and drugstore chains. The results of this study are shared in this 2017 Retail Vision Study.
Unique serial numbers must now be applied to individual bottles of drugs and the cases that carry them in California, due to new tracking requirements. Read this white paper to learn how the IBM Serialization Pilot Kit with TAGSYS RFID is helping companies achieve compliance in less than a year.
Physicians and their patients, medical policy makers and licensing boards, pharmaceutical companies and pharmacies all must work together to stem the opioid epidemic and achieve the fundamental objectives of reducing addiction and deaths. With so many players and data sources, today’s information is partial, fragmented, and often not actionable. We don’t have the data to understand what’s happening, to adjust policy, and to motivate physicians and patients to change their behaviors.
Better data and analytics can help develop better treatment protocols, both for pain in the first place and for remediation when patients are becoming dependent on the drugs.
Published By: YouSendIt
Published Date: Jul 18, 2011
This case study illustrates how AMAG drastically cut completion time of critical projects by eliminating e-mail transfer of large files, ultimately improving security, increasing cost-savings and accelerating time to market.
Published By: Accelrys
Published Date: Feb 08, 2012
This Perspective highlights Accelrys' Biological Registration, a new product solution with the ability to more effectively register, track, and manage promising biologics, resulting in more efficient biological product development. Find out more!